U S PHYSICAL THERAPY INC /NV
USPHUS売上高
$781M
百万USD
営業利益
$87M
百万USD
純利益
$40M
百万USD
ROE
8.3%
最新FY
EPS
$1.42
USD / 株
配当
$1.80
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $112M | $8M | $0.21 |
| FY2021 | Q2 | $127M | $12M | $0.82 |
| FY2021 | Q3 | $126M | $10M | $0.66 |
| FY2021 | FY | $495M | $41M | $2.41 |
| FY2022 | Q1 | $132M | $9M | $0.67 |
| FY2022 | Q2 | $141M | $11M | $0.87 |
| FY2022 | Q3 | $140M | $10M | $0.72 |
| FY2022 | FY | $553M | $32M | $2.25 |
| FY2023 | Q1 | $149M | $7M | $0.58 |
| FY2023 | Q2 | $151M | $11M | $0.64 |
| FY2023 | Q3 | $150M | $9M | $0.51 |
| FY2023 | FY | $605M | $28M | $1.28 |
| FY2024 | Q1 | $156M | $8M | $0.46 |
| FY2024 | Q2 | $167M | $8M | $0.47 |
| FY2024 | Q3 | $168M | $7M | $0.39 |
| FY2024 | FY | $671M | $31M | $1.84 |
| FY2025 | Q1 | $184M | $10M | $0.80 |
| FY2025 | Q2 | $197M | $12M | $0.58 |
| FY2025 | Q3 | $197M | $13M | $0.48 |
| FY2025 | FY | $781M | $40M | $1.42 |
| FY2026 | Q1 | $198M | $5M | $-0.12 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $454M | $482M | $423M | $495M | $553M | $605M | $671M | $781M |
| 営業利益 | $50M | $55M | $60M | $67M | $52M | $71M | $57M | $52M | $63M | $87M |
| 純利益 | $21M | $22M | $35M | $40M | $35M | $41M | $32M | $28M | $31M | $40M |
| 総資産 | $351M | $419M | $443M | $561M | $594M | $749M | $858M | $997M | $1.2B | $1.2B |
| 純資産 | $189M | $206M | $217M | $242M | $278M | $297M | $317M | $477M | $490M | $477M |
| 自己資本 | $188M | $205M | $216M | $240M | $276M | $296M | $316M | $476M | $489M | $476M |
| 営業CF | - | $57M | $73M | $62M | $100M | $76M | $59M | $82M | $75M | $75M |
| EPS | - | - | - | - | - | $2.41 | $2.25 | $1.28 | $1.84 | $1.42 |
| BPS | $14.91 | $16.17 | $16.92 | $18.81 | $21.41 | $22.83 | $24.24 | $31.60 | $32.18 | $31.50 |
| ROE | 11.0% | 10.9% | 16.1% | 16.7% | 12.7% | 13.8% | 10.2% | 5.9% | 6.4% | 8.3% |